Effect of neoadjuvant chemotherapy on estrogen receptor, progesterone receptor, Cerb-B-2, vascular endothelial growth factor and Ki-67 in patients with locally advanced breast cancer

SARITAŞ, AHMET; YALAV, ORÇUN; Kekec, Yalcin; SAKMAN, GÜRHAN; BAĞIR KILIÇ, EMİNE; ZORLUDEMİR, SUZAN; ERGİN, MELEK; Eray, Tsmail; Kara, Tsmail; PAYDAŞ, SEMRA

doi:10.17826/cumj.412192

Effect of neoadjuvant chemotherapy on estrogen receptor, progesterone receptor, Cerb-B-2, vascular endothelial growth factor and Ki-67 in patients with locally advanced breast cancer

SARITAŞ A. G., YALAV O., Kekec Y., SAKMAN G., BAĞIR KILIÇ E., ZORLUDEMİR S., ...Daha Fazla

CUKUROVA MEDICAL JOURNAL, cilt.44, sa.1, ss.226-231, 2019 (ESCI, TRDizin)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 44 Sayı: 1
Basım Tarihi: 2019
Doi Numarası: 10.17826/cumj.412192
Dergi Adı: CUKUROVA MEDICAL JOURNAL
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.226-231
Çukurova Üniversitesi Adresli: Evet

Özet

Purpose: The aim of this study is aimed to demonstrate the changes in the tumor diameter and expressions of vascular endothelial growth factor (VEGF), estrogen receptor (ER), progesterone receptor (PR), Ki-67, and Cerb-B2 status after neoadjuvant chemotherapy in the patients with locally advanced breast cancer.